ライフサイエンスコーパス: anti-inflammatory agent

1 al agent, and 5-amino-salicylate (5-ASA), an anti-inflammatory agent.

2 an adipocyte-specific insulin sensitizer and anti-inflammatory agent.

3 g to explore its therapeutic potential as an anti-inflammatory agent.

4 ity of berberine to act as an anticancer and anti-inflammatory agent.

5 thway selective, estrogen receptor dependent anti-inflammatory agent.

6 A-IV suggest that this protein may act as an anti-inflammatory agent.

7 telet aggregation, and functions as a potent anti-inflammatory agent.

8 -Met-Leu-Phe (fMLP) and therefore acts as an anti-inflammatory agent.

9 in inflammation and that NFP is an effective anti-inflammatory agent.

10 asone, a synthetic glucocorticoid and potent anti-inflammatory agent.

11 e, has recently garnered much interest as an anti-inflammatory agent.

12 es, has recently been identified as a potent anti-inflammatory agent.

13 omotes vascularization, or dexamethasone, an anti-inflammatory agent.

14 o hydrazide 6P was identified as a promising anti-inflammatory agent.

15 c osteoarthritis managed with a nonsteroidal anti-inflammatory agent.

16 h both a neuroprotective neurotrophin and an anti-inflammatory agent.

17 that EDP might be a natural antioxidant and anti-inflammatory agent.

18 e, reinforcing the use of EP2 antagonists as anti-inflammatory agents.

19 ent a highly promising class of antiviral or anti-inflammatory agents.

20 inflammation without the need for exogenous anti-inflammatory agents.

21 hloride, are also used as neuroprotective or anti-inflammatory agents.

22 osphate may function as novel antithrombotic/anti-inflammatory agents.

23 is pathway might indirectly be responsive to anti-inflammatory agents.

24 i-influenza drugs formed by conjugation with anti-inflammatory agents.

25 omoters of reverse cholesterol transport and anti-inflammatory agents.

26 ic acid is a major target for development of anti-inflammatory agents.

27 c AMP and is a target for the development of anti-inflammatory agents.

28 ractive therapeutic target for analgesic and anti-inflammatory agents.

29 s 8Br-ADPR, have the potential to be used as anti-inflammatory agents.

30 may improve the therapeutic index of future anti-inflammatory agents.

31 rventions based on modulation of immunity by anti-inflammatory agents.

32 through the administration of non-steroidal anti-inflammatory agents.

33 expression have been considered as potential anti-inflammatory agents.

34 ion and provide a template for the design of anti-inflammatory agents.

35 ription factors, iron chelators may serve as anti-inflammatory agents.

36 Cyclooxygenase-2 inhibitors are potent anti-inflammatory agents.

37 or TLR-4, with possible uses as adjuvants or anti-inflammatory agents.

38 e and acetylsalicylic acid are drugs used as anti-inflammatory agents.

39 roteinase-activated receptor 2 may be useful anti-inflammatory agents.

40 by VIP and PACAP positions them as important anti-inflammatory agents.

41 for the assessment of anti-hyperalgesic and anti-inflammatory agents.

42 phoid microenvironment that act primarily as anti-inflammatory agents.

43 uld offer a significant advantage over other anti-inflammatory agents.

44 or derivatives may have therapeutic uses as anti-inflammatory agents.

45 tudy as a lead compound for developing novel anti-inflammatory agents.

46 nes, mast cell stabilizers, and nonsteroidal anti-inflammatory agents.

47 intriguing target for new antibacterial and anti-inflammatory agents.

48 on catalysts may represent a unique class of anti-inflammatory agents.

49 l elastase are evaluated for clinical use as anti-inflammatory agents.

50 the target of aspirin and other nonsteroidal anti-inflammatory agents.

51 o determine in vivo efficacy of inotropes as anti-inflammatory agents.

52 s and peroxynitrite scavengers may be useful anti-inflammatory agents.

53 rials demonstrating that they are reasonable anti-inflammatory agents.

54 nhibitors demonstrate significant promise as anti-inflammatory agents.

55 Biomaterials can act as pro- or anti-inflammatory agents.

56 aDry, and its expression was not affected by anti-inflammatory agents.

57 nflammation, suggesting a potential role for anti-inflammatory agents.

58 change in total psychopathology in favor of anti-inflammatory agents.

59 posing or engineering Evasins as therapeutic anti-inflammatory agents.

60 ions for future therapeutic trials involving anti-inflammatory agents.

61 llenging to treat and may require the use of anti-inflammatory agents.

62 ic options such as complement inhibitors and anti-inflammatory agents.

63 rug targets for development of anticancer or anti-inflammatory agents.

64 tory activity may limit their development as anti-inflammatory agents.

65 selective agonists of the A2AAR as potential anti-inflammatory agents.

66 timicrobials, antivirals, and anticancer and anti-inflammatory agents.

67 ocorticoids are among the most commonly used anti-inflammatory agents.

68 for structure-based design of analgesic and anti-inflammatory agents.

69 tractive target for the development of novel anti-inflammatory agents.

70 t the use of catalytic inhibitors of USP7 as anti-inflammatory agents.

71 dverse effects may contraindicate the use of anti-inflammatory agents.

72 l class of broadly active anti-infective and anti-inflammatory agents.

73 In contrast, the anti-inflammatory agent 10-nitro-oleic acid (NO2-OA), a

74 Clinical trials using alternative anti-inflammatory agents active against the CRP/IL-6/IL-

75 ow current management principles (eg, use of anti-inflammatory agents, adequate removal of fibrovascu

76 s, neuroprotectants, photobiomodulation, and anti-inflammatory agents against the development and pro

77 Scleritis resolved with oral nonsteroidal anti-inflammatory agent alone in 1 patient (8%).

78 odel suggests that there could be a role for anti-inflammatory agents, alone or in combination with H

79 It is commonly classified as an anti-inflammatory agent, although its mechanism of actio

80 ilities of detoxification and can work as an anti-inflammatory agent and an anti-oxidant.

81 trations of ibuprofen (IBF), a non-steroidal anti-inflammatory agent and prevalent environmental cont

82 on suggesting a link between a low-dose oral anti-inflammatory agent and subclinical improvement in i

83 the disease, including antifibrotic agents, anti-inflammatory agents and antioxidants.

84 e gold(I) complexes behave as very effective anti-inflammatory agents and could prove to be useful fo

85 osed role of VIP and PACAP as key endogenous anti-inflammatory agents and describe a novel mechanism,

86 istic understanding of the mode of action of anti-inflammatory agents and designing more effective tr

87 uently suffer adverse effects from long-term anti-inflammatory agents and have a quality of life that

88 ammation; infections; and clinical trials of anti-inflammatory agents and immunotherapy.

89 Although a link between low-dose oral anti-inflammatory agents and subclinical improvement in

90 s on brain health, their biological roles as anti-inflammatory agents and their therapeutic role on c

91 rs to take a closer look at more traditional anti-inflammatory agents and to explore novel therapeuti

92 o compounds, dexamethasone, a glucocorticoid anti-inflammatory agent, and XJB-5-131, a mitochondriall

93 s as an anti-coagulant, profibrinolytic, and anti-inflammatory agent, and, thus, its administration o

94 is is diagnosed, treatment consists of rest, anti-inflammatory agents, and a tincture of time.

95 cal treatments include neuroregenerative and anti-inflammatory agents, and first-line systemic pharma

96 uppress or eradicate bacterial colonization, anti-inflammatory agents, and new approaches that improv

97 ovel therapies - including senotherapeutics, anti-inflammatory agents, and stem cell treatments - sho

98 novel molecular mechanism for the action of anti-inflammatory agents, and suggest the possibility of

99 eed to be used in combination with effective anti-inflammatory agents, and that pathways mediating os

100 s that counteract free haemoglobin and haem, anti-inflammatory agents, anti-thrombotic agents and ant

101 tive cargos, such as chemotherapeutic drugs, anti-inflammatory agents, antibacterial compounds, and p

102 infusions, judicious opioids, acetaminophen, anti-inflammatory agents, anticonvulsants, ketamine, clo

103 ical implications, as indomethacin and other anti-inflammatory agents are administered to premature i

104 A variety of safe and effective anti-inflammatory agents are available, including aspiri

105 Nonsteroidal anti-inflammatory agents are not associated with an incr

106 Anti-inflammatory agents are probably most effective in

107 lation in the pathogenesis of schizophrenia, anti-inflammatory agents are promising adjunctive treatm

108 y, diclofenac is found to be as effective an anti-inflammatory agent as prednisolone.

109 e to support the development of nonsteroidal anti-inflammatory agents as chemopreventives for colorec

110 ification scale indicates the use of inhaled anti-inflammatory agents as maintenance medications and

111 mon bean extracts may be used as a source of anti-inflammatory agents as well as a dietary complement

112 Here we demonstrate that the anti-inflammatory agents aspirin and sodium salicylate s

113 In vivo studies by encapsulating anti-inflammatory agents (aspirin and naproxen) in these

114 art, the beneficial effects of aspirin as an anti-inflammatory agent at therapeutic concentrations, w

115 Glucocorticoid hormones are important anti-inflammatory agents because of their anti-inflammat

116 Glucocorticoids (GC) are potent anti-inflammatory agents, broadly used to treat acute an

117 this technology enhanced the efficacy of the anti-inflammatory agent, budesonide, allowing for prophy

118 Corticosteroids are potent anti-inflammatory agents, but corticosteroid insensitivi

119 Glucocorticoids (GCs) are widely prescribed anti-inflammatory agents, but their chronic use leads to

120 Glucocorticoids are powerful, broad-spectrum anti-inflammatory agents, but their use is complicated b

121 TZDs), are effective insulin sensitizers and anti-inflammatory agents, but their use is limited by ad

122 StcE acts first as a mucinase and then as an anti-inflammatory agent by localizing C1-INH to cell mem

123 ese data also suggest that L-NMMA acts as an anti-inflammatory agent by specifically altering the bal

124 sequelae from irradiation and non-steroidal anti-inflammatory agents can restore neurogenesis then a

125 mitigated by treatment with minocycline, an anti-inflammatory agent capable of crossing the blood-br

126 n resonance, that dimethyl celecoxib and the anti-inflammatory agent celecoxib can bind cadherin-11,

127 ght into the chemopreventive activity of the anti-inflammatory agent celecoxib.

128 Finally, we also assessed the ability of the anti-inflammatory agent, celecoxib, to suppress hyperemi

129 ceptible to gastric injury from nonsteroidal anti-inflammatory agents, confirming that trefoil peptid

130 onditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective

131 ing the functions of these S. aureus-derived anti-inflammatory agents could also provide the platform

132 ry induced by toxicants can be treated using anti-inflammatory agents coupled with Tbeta4.

133 -dependent protein kinase inhibitor; and the anti-inflammatory agent dexamethasone (10 microM).

134 or necrosis factor-alpha (TNF-alpha) and the anti-inflammatory agent dexamethasone in human alveolar

135 compared the effects of MLN4924 with a known anti-inflammatory agent (dexamethasone), on certain proi

136 is to evaluate the therapeutic effect of two anti-inflammatory agents, dexamethasone and ketorolac, c

137 therapy includes steroidal and non-steroidal anti-inflammatory agents, disease-modifying agents, and

138 attenuated, and the addition of nonsteroidal anti-inflammatory agents does not further impair the res

139 Second, can anti-inflammatory agents effectively treat existing neur

140 ribute most to CVD risk and whether specific anti-inflammatory agents, either alone or in combination

141 ese hypertonic solutions may prove useful as anti-inflammatory agents, especially against conditions

142 An anti-inflammatory agent (etanercept) is administered for

143 ffer preclinical evidence that the low-cost, anti-inflammatory agent ethyl pyruvate elicits a potent

144 death and that caspase inhibitors can act as anti-inflammatory agents, evaluation of ischemic death m

145 eptide, C-L, could be developed into a novel anti-inflammatory agent for animals or humans.

146 e (AP) is currently being investigated as an anti-inflammatory agent for detoxifying LPS through deph

147 beta-Carotene can be considered a potential anti-inflammatory agent for DNA-virus infection.

148 rate and may offer significant promise as an anti-inflammatory agent for gingival surgery.

149 Desulfated heparin (ODSH) is a promising new anti-inflammatory agent for the prevention of reperfusio

150 Infliximab is used successfully as a potent anti-inflammatory agent for the treatment of chronic inf

151 TLR4A could have promise as an anti-inflammatory agent for the treatment or prevention

152 that Ba has significant potential as a novel anti-inflammatory agent for therapy of autoimmune diseas

153 analysis provided support for repurposing of anti-inflammatory agents for SCZ, amantadine for BD, ret

154 Glucocorticoids represent the most effective anti-inflammatory agents for the treatment of several in

155 CQA at 25 mumol/l can be qualified as potent anti-inflammatory agents for treating inflammation-relat

156 is a long-standing, proven antibacterial and anti-inflammatory agent found in the only Food and Drug

157 Treatment is with non-steroidal anti-inflammatory agents, four to six weeks of limited e

158 luation of these potential antisecretory and anti-inflammatory agents from the laboratory into clinic

159 ional analgesia, acetaminophen, nonsteroidal anti-inflammatory agents, gabapentinoids, tramadol, lido

160 ion or treatment, what is the best choice of anti-inflammatory agent given the basic science mechanis

161 We conclude that the endogenous anti-inflammatory agent GPI may ameliorate BBB function

162 To date, no anti-inflammatory agent has been clinically approved for

163 The clinical use of IL-10 as an anti-inflammatory agent has, however, not met expectatio

164 elial-derived growth factor antagonists, and anti-inflammatory agents have been investigated for trea

165 However, emerging data on new anti-inflammatory agents have been published in the rece

166 Anti-inflammatory agents have the potential to not only

167 ical scavengers, ion channel modulators, and anti-inflammatory agents, have been extensively explored

168 Long-term treatment using anti-inflammatory agents, however, can be associated wit

169 ti-cyclooxygense-2IC50>1) than non-steroidal anti-inflammatory agent ibuprofen (0.44) described the s

170 The anti-inflammatory agent ibuprofen inhibited the constitu

171 was first reported to produce the cyclomarin anti-inflammatory agents, illuminated the biosynthetic b

172 l pyruvate has been shown to be an effective anti-inflammatory agent in a variety of in vitro and in

173 ich was potent in vitro and was active as an anti-inflammatory agent in an animal model and had antin

174 ur knowledge, the external application of an anti-inflammatory agent in animals.

175 d suggest that BCX 1470 will be useful as an anti-inflammatory agent in diseases where complement act

176 at purslane could be considered as a natural anti-inflammatory agent in further applications.

177 nocyte-stimulating hormone (MSH) is a potent anti-inflammatory agent in many models of inflammation,

178 ylphthalimide derivative 6P acts as a potent anti-inflammatory agent in the carrageenan-induced lung

179 DHA(22:6n3) could be an important anti-inflammatory agent in the face of increased cytokin

180 treatment strategy should include the use of anti-inflammatory agents in addition to antibiotics.

181 in amides are orally active, nonulcerogenic, anti-inflammatory agents in an in vivo model of acute in

182 is method is amenable to rapid evaluation of anti-inflammatory agents in animal models.

183 tified deficits in the use of spirometry and anti-inflammatory agents in caring for asthmatic patient

184 vated receptor gamma (PPARgamma) agonists as anti-inflammatory agents in cell-based assays and in a m

185 th) rates between celecoxib and nonsteroidal anti-inflammatory agents in CLASS.

186 , and points to a potential role for topical anti-inflammatory agents in moderating the initial propa

187 ings support a beneficial effect of biologic anti-inflammatory agents in preventing cardiovascular di

188 than the combination therapy with ZA and the anti-inflammatory agents in protection of the lethally i

189 hese findings support the beneficial role of anti-inflammatory agents in reducing the incidence of he

190 vectors expressing vIL-10 may have a role as anti-inflammatory agents in the treatment of acute and c

191 such as HNK have promise as a novel class of anti-inflammatory agents in the treatment of chronic ast

192 oids are the most potent and widely accepted anti-inflammatory agents in the treatment of pathologica

193 r polyphosphate inhibitors as antithrombotic/anti-inflammatory agents in vitro and in vivo, with a no

194 f compounds may be effective neuroprotective anti-inflammatory agents in vivo.

195 In particular, the new era of anti-inflammatory agents includes "biologicals" such as

196 nt work has suggested that some nonsteroidal anti-inflammatory agents, including sodium salicylate an

197 phthalmic solution 5% (Xiidra((R)); LFT) are anti-inflammatory agents indicated for DED.

198 B is a downstream target of the nonsteroidal anti-inflammatory agent indomethacin and is involved in

199 The nonsteroidal anti-inflammatory agent indomethacin reduced inflammatio

200 d response may be abrogated with the classic anti-inflammatory agent indomethacin.

201 e present study, we investigated whether the anti-inflammatory agent, indomethacin, could inhibit mon

202 thesized that a low-dose dexamethasone (Dex; anti-inflammatory agent) infusion during endotoxaemia wo

203 ventions (aminophyllines, magnesium sulfate, anti-inflammatory agents, inhaled corticosteroids, and s

204 The knowledge of how anti-inflammatory agents inhibit cancer formation and pr

205 Non-steroidal anti-inflammatory agents inhibit the production of cyclo

206 also has been demonstrated that nonsteroidal anti-inflammatory agents inhibit tumor necrosis factor a

207 Methotrexate (MTX), a potent anti-inflammatory agent, inhibits cellular DHFR activity

208 However, when treatment with an anti-inflammatory agent is initiated during the first 2

209 ed neurotrophic factor (GDNF), and the model anti-inflammatory agent is the type II tumor necrosis fa

210 ne (a benzophenanthridine alkaloid), a known anti-inflammatory agent, is a potent inhibitor of NF-kap

211 Similarly, anti-inflammatory agents, junctional protein regulators,

212 tory activity compared with the nonsteroidal anti-inflammatory agent ketorolac.

213 The nonsteroidal anti-inflammatory agents ketorolac tromethamine and dicl

214 asily be conjugated to another non-steroidal anti-inflammatory agent, leading to easy synthesis of hy

215 ' previous studies demonstrated that a novel anti-inflammatory agent, lisofylline (LSF), suppressed a

216 Anti-inflammatory agents may accelerate the host into im

217 Thus, the fact that anti-inflammatory agents may alter CTpr levels resulting

218 Of importance, this study reveals that anti-inflammatory agents may modulate the CTpr level, wh

219 rodevelopmental dysfunction and suggest that anti-inflammatory agents may prove effective for treatme

220 s, SCD1 inhibitors given in conjunction with anti-inflammatory agents may provide a useful strategy t

221 Colchicine, an established anti-inflammatory agent, may reduce these symptoms by ta

222 Topical treatment of EDE with the anti-inflammatory agents methylprednisolone or doxycycli

223 Furthermore, in vivo administration of the anti-inflammatory agent minocycline attenuates nigrostri

224 in 202 rats treated with combinations of an anti-inflammatory agent (minocycline), a neurotrophic ag

225 Coexposure to resatorvid, an anti-inflammatory agent, mitigated inflammatory response

226 We also demonstrate that anti-inflammatory agents modulating transcription via th

227 cells created by excess of antioxidative and anti-inflammatory agents NAC and mito-Q, resulting in th

228 failure, as well as TD139 and Arglabin, two anti-inflammatory agents new to cardiac diseases, to pre

229 s of azo mutual prodrugs of the nonsteroidal anti-inflammatory agents (NSAIDs) 4-aminophenylacetic ac

230 Non-steroidal anti-inflammatory agents (NSAIDs) are associated with a

231 Nonsteroidal anti-inflammatory agents (NSAIDS) inhibit growth of vari

232 included patients using aspirin/nonsteroidal anti-inflammatory agents (NSAIDs) or acid-suppressing dr

233 Topical nonsteroidal anti-inflammatory agents (NSAIDs) proved to have the gre

234 Sulfasalazine (SSZ) an FDA approved anti-inflammatory agent of unknown mechanism of action,

235 utilized for the synthesis of Sch-21418, an anti-inflammatory agent on gram scale.

236 ired to determine the deleterious effects of anti-inflammatory agents on basic ovarian processes.

237 evaluate the effect of luteolin, a powerful anti-inflammatory agent, on the prevention of experiment

238 We uncovered that pro- and anti-inflammatory agents oppositely regulate KLF6 and mi

239 Nonsteroidal anti-inflammatory agents or corticosteroids may potentia

240 Nonsteroidal anti-inflammatory agents or NSAIDs are potent inhibitors

241 d treatments (e.g., laser photocoagulation), anti-inflammatory agents, or other non-VEGF-based antian

242 These data indicate that EP4 agonists as anti-inflammatory agents represent a potential therapy f

243 The anti-inflammatory agents, secoisolariciresinol diglucosi

244 Clinical studies examining the potential of anti-inflammatory agents, specifically of minocycline, a

245 presence of a protolerogenic and purportedly anti-inflammatory agent such as IL-10 precludes DCs from

246 Other anti-inflammatory agents such as cromolyn and the new cl

247 Therapy with nonspecific anti-inflammatory agents such as statins in patients wit

248 can overcome physiologic barriers and target anti-inflammatory agents such as the peptide KPV to infl

249 Treatment studies of anti-inflammatory agents, such as celecoxib and aspirin,

250 Exposure of human monocytes/macrophages to anti-inflammatory agents, such as IL-10 or glucocorticoi

251 Anti-inflammatory agents, such corticosteroids, NSAIDs a

252 n urine cannot be suppressed by nonsteroidal anti-inflammatory agents, suggesting that it is generate

253 on of TP expression in monocytes by pro- and anti-inflammatory agents suggests that its angiogenic-re

254 orally given aspirin and clopidogrel or the anti-inflammatory agent sulindac vs mice on a chow (cont

255 risingly, glucocorticoids, well known potent anti-inflammatory agents, synergistically enhance NTHi-i

256 ighlight the need for a second generation of anti-inflammatory agents targeting atherosclerosis-speci

257 ilbene-2,2'-disulfonic acid, UK5099, and the anti-inflammatory agent tenidap.

258 Pomalidomide is a significantly more potent anti-inflammatory agent than either Thalidomide or Lenal

259 re potent COX-2 inhibitors and orally active anti-inflammatory agents than the corresponding methyl s

260 re these polymers represent a novel class of anti-inflammatory agent that can act as molecular scaven

261 -stimulating hormone (alpha-MSH) is a potent anti-inflammatory agent that inhibits neutrophil migrati

262 Curcumin is a known natural anti-inflammatory agent that inhibits pathological autoi

263 Curcumin is an anti-inflammatory agent that inhibits the complement cas

264 Sulindac is a non-steroidal anti-inflammatory agent that is related both structurall

265 N-acetylcysteine is an antioxidant and anti-inflammatory agent that may counteract some of the

266 arly A(2A) receptors, is a potent endogenous anti-inflammatory agent that modulates the functions and

267 BCP is a potent anti-inflammatory agent that showed substantial antihype

268 demonstrated that both compounds are potent anti-inflammatory agents that are active on local intrav

269 This could lead to more specific anti-inflammatory agents that are both more effective an

270 Glucocorticoids (GCs) are potent anti-inflammatory agents that block cytokine production.

271 aspirin-triggered 15-epimers are endogenous anti-inflammatory agents that block neutrophil chemotaxi

272 monic pasteurellosis, development and use of anti-inflammatory agents that inhibit LKT-induced activa

273 activating polypeptide (PACAP) act as potent anti-inflammatory agents that inhibit the function of ac

274 ators, glycoprotein IIb/IIIa inhibitors, and anti-inflammatory agents that may reduce microvascular o

275 d the J series of prostaglandins, are potent anti-inflammatory agents that prevent cytokine- and endo

276 be described as a newly recognized family of anti-inflammatory agents that share the property of usin

277 urce of enzyme to help in the search for new anti-inflammatory agents that target the final processin

278 Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to

279 Beyond the conventional mode of working of anti-inflammatory agents through enzyme inhibition, here

280 , we assessed the ability of antioxidant and anti-inflammatory agents to affect skeletal and cellular

281 Gene delivery of anti-inflammatory agents to combat the inflammatory casc

282 n significant promise as neuroprotective and anti-inflammatory agents to treat chronic neuronal damag

283 This system may serve as a promising anti-inflammatory agent toward the treatment of acute lu

284 participants and to determine effects of the anti-inflammatory agent triclosan on the TLR-hyper-infla

285 esolution of nonbloody effusions may require anti-inflammatory agents, tube thoracostomy, or intraple

286 us, Pap test diagnosis, immunosuppressant or anti-inflammatory agent use, and number of sex partners.

287 a-lipoic acid (LA), a potent antioxidant and anti-inflammatory agent used in therapeutic applications

288 Curcumin (diferuloylmethane), an anti-inflammatory agent used in traditional medicine, ha

289 coid dexamethasone, an immunosuppressive and anti-inflammatory agent, was investigated for its effect

290 All of the amphiphilic anti-inflammatory agents we tested had similar effects o

291 dose of HCT 1026, a NO-donating nonsteroidal anti-inflammatory agent which has previously been shown

292 OC000459 is a safe and effective oral anti-inflammatory agent, which achieved clinically meani

293 Glucocorticoids are potent anti-inflammatory agents widely used in the treatment of

294 (DMF) is an FDA approved anti-oxidative and anti-inflammatory agent with a favorable safety record.

295 We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogen

296 rescribed antimicrobial drug that acts as an anti-inflammatory agent with broad inhibitory properties

297 nd dibenzosuberane sulfonamides, is a potent anti-inflammatory agent with selectivity for the GR vers

298 therefore might act as novel antithrombotic/anti-inflammatory agents with reduced bleeding side effe

299 ptomatic relief as nonselective nonsteroidal anti-inflammatory agents without the same concerns over

300 ASA) and dexamethasone (DEX) are widely used anti-inflammatory agents yet their mechanism(s) for bloc